TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $319 | -99.4% | 21,224 | +74.1% | 0.03% | +750.0% |
| Q2 2022 | $52,000 | -73.5% | 12,191 | -40.7% | 0.00% | -73.3% |
| Q1 2022 | $196,000 | -22.2% | 20,565 | +216.7% | 0.02% | -37.5% |
| Q2 2021 | $252,000 | -72.1% | 6,493 | -62.5% | 0.02% | -75.3% |
| Q4 2020 | $902,000 | +342.2% | 17,330 | +65.4% | 0.10% | +304.2% |
| Q2 2020 | $204,000 | -43.5% | 10,477 | -67.8% | 0.02% | -31.4% |
| Q4 2019 | $361,000 | +423.2% | 32,551 | +165.2% | 0.04% | +600.0% |
| Q3 2019 | $69,000 | -67.3% | 12,273 | -76.2% | 0.01% | -54.5% |
| Q4 2018 | $211,000 | +263.8% | 51,570 | +399.5% | 0.01% | +175.0% |
| Q3 2018 | $58,000 | -88.8% | 10,325 | -71.8% | 0.00% | -85.7% |
| Q1 2018 | $520,000 | +37.6% | 36,592 | -20.5% | 0.03% | +40.0% |
| Q4 2017 | $378,000 | +58.8% | 46,055 | +129.0% | 0.02% | +66.7% |
| Q3 2017 | $238,000 | – | 20,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |